Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

Researchers at Boston-based Mass General Brigham and MIT have developed a long-acting contraceptive injection designed to be delivered through tiny needles, reducing discomfort and increasing ...

The FINANCIAL — Pfizer Inc. announced on September 24 that the company’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for ...

Researchers evaluated the association between the use of various hormonal contraceptives and the risk for surgically treated intracranial meningioma.

The scientific studysuggests that women who receive the injections are 40 per cent more likely to be infected with the virus than women who use other contraceptive methods or none at all. The study, ...

The Society for Family Health has said that the introduction of Depot Medroxyprogesterone Acetate (DMPASC), a self-injectable contraceptive, has significantly expanded the options available to ...